阅读说明：本技术 Cdk4/6抑制剂与vegfr抑制剂联合在制备治疗肿瘤的药物中的用途 (Application of CDK4/6 inhibitor and VEGFR inhibitor in preparation of drugs for treating tumors ) 是由 张岚 林侃 廖成 张连山 孙飘扬 于 2020-05-29 设计创作，主要内容包括：CDK4/6抑制剂与VEGFR抑制剂联合在制备治疗肿瘤疾病的药物中的用途。具体而言,CDK4/6抑制剂为式(I)所示化合物或其可药用盐,VEGFR抑制剂为阿帕替尼或其可药用盐。(Use of a CDK4/6 inhibitor in combination with a VEGFR inhibitor in the preparation of a medicament for the treatment of a neoplastic disease. Specifically, the CDK4/6 inhibitor is a compound shown as a formula (I) or a pharmaceutically acceptable salt thereof, and the VEGFR inhibitor is apatinib or a pharmaceutically acceptable salt thereof.)